Knight Therapeutics Stock Analysis
| GUD Stock | CAD 5.54 0.23 3.99% |
Knight Therapeutics is overvalued with Real Value of 4.61 and Hype Value of 5.54. The main objective of Knight Therapeutics stock analysis is to determine its intrinsic value, which is an estimate of what Knight Therapeutics is worth, separate from its market price. There are two main types of Knight Therapeutics' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Knight Therapeutics' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Knight Therapeutics' stock to identify patterns and trends that may indicate its future price movements.
The Knight Therapeutics stock is traded in Canada on Toronto Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Canada. Knight Therapeutics is usually not traded on Civic Holiday, Labour Day, Thanksgiving Day, Christmas Day, Boxing Day, New Year 's Day, Family Day, Good Friday, Victoria Day, Canada Day. Knight Stock trading window is adjusted to America/Toronto timezone.
Knight |
Knight Stock Analysis Notes
The company has Price/Earnings (P/E) ratio of 133.9. Knight Therapeutics recorded a loss per share of 0.16. The entity had not issued any dividends in recent years. Knight Therapeutics Inc. operates as a specialty pharmaceutical company in Canada and internationally. The company was incorporated in 2013 and is headquartered in Montreal, Canada. KNIGHT THERAPEUTICS operates under Drug ManufacturersSpecialty Generic classification in Canada and is traded on Toronto Stock Exchange. To learn more about Knight Therapeutics call Jonathan Goodman at 514 484 4483 or check out https://www.gud-knight.com.Knight Therapeutics Quarterly Total Revenue |
|
Knight Therapeutics Investment Alerts
| Knight Therapeutics generated a negative expected return over the last 90 days | |
| The company reported the revenue of 328.2 M. Net Loss for the year was (16.84 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Latest headline from news.google.com: Knight Therapeutics Shares Down 0.2 percent - Whats Next - MarketBeat |
Knight Largest EPS Surprises
Earnings surprises can significantly impact Knight Therapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2019-05-09 | 2019-03-31 | 0.03 | 0.04 | 0.01 | 33 | ||
2018-05-10 | 2018-03-31 | 0.04 | 0.05 | 0.01 | 25 | ||
2018-03-15 | 2017-12-31 | 0.04 | 0.05 | 0.01 | 25 |
Knight Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 576.83 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Knight Therapeutics's market, we take the total number of its shares issued and multiply it by Knight Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Knight Profitablity
Knight Therapeutics' profitability indicators refer to fundamental financial ratios that showcase Knight Therapeutics' ability to generate income relative to its revenue or operating costs. If, let's say, Knight Therapeutics is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Knight Therapeutics' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Knight Therapeutics' profitability requires more research than a typical breakdown of Knight Therapeutics' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.03) | (0.03) | |
| Return On Assets | (0.02) | (0.02) | |
| Return On Equity | (0.03) | (0.02) |
Technical Drivers
As of the 1st of February, Knight Therapeutics secures the Risk Adjusted Performance of 0.0254, downside deviation of 2.44, and Mean Deviation of 1.05. Knight Therapeutics technical analysis lets you operate historical price patterns with an objective to determine a pattern that forecasts the direction of the firm's future prices.Knight Therapeutics Price Movement Analysis
The output start index for this execution was twenty-nine with a total number of output elements of thirty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Knight Therapeutics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Knight Therapeutics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Knight Therapeutics Predictive Daily Indicators
Knight Therapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Knight Therapeutics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 4861.91 | |||
| Daily Balance Of Power | (0.77) | |||
| Rate Of Daily Change | 0.96 | |||
| Day Median Price | 5.66 | |||
| Day Typical Price | 5.62 | |||
| Price Action Indicator | (0.23) | |||
| Period Momentum Indicator | (0.23) |
Knight Therapeutics Forecast Models
Knight Therapeutics' time-series forecasting models are one of many Knight Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Knight Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Knight Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Knight Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Knight shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Knight Therapeutics. By using and applying Knight Stock analysis, traders can create a robust methodology for identifying Knight entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (0.08) | (0.07) | |
| Operating Profit Margin | (0.01) | (0.01) | |
| Net Loss | (0.06) | (0.06) | |
| Gross Profit Margin | 0.53 | 0.65 |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Knight Therapeutics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Analyst Advice Now
Analyst AdviceAnalyst recommendations and target price estimates broken down by several categories |
| All Next | Launch Module |
Other Information on Investing in Knight Stock
Knight Therapeutics financial ratios help investors to determine whether Knight Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Knight with respect to the benefits of owning Knight Therapeutics security.